Effect of IL-18 on leukocyte expression of iNOS and phospho-IκB in patients with squamous cell carcinoma of the oral cavity

Neoplasma

Volumn 53, Issue 3, 2006, Pages 200-205

  Jablonska E ^a   Puzewska W ^a   Charkiewicz, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Inducible synthase of nitric oxide; Neutrophils; NF B; Nitric oxide; Peripheral blood mononuclear cells; Squamous cell oral cancer

Indexed keywords

INTERLEUKIN 18; NITRIC OXIDE; SYNTHETASE;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKOCYTE; MOUTH CANCER; MOUTH CAVITY; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SUPERNATANT; WESTERN BLOTTING;

EID: 33744930371     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. DI CARLO E, FORNI G, LOLLINI PL, COLOMBO MP, MODESTI A et al. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001; 97: 339-345.
2. DI WU Q, WANG JH, CONDRON C, BOUCHIER-HAYES D, REDMOND HP. Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol 2001; 280: 814-822.
3. STOPPACCIARO A, MELANI C, PARENZA M, MASTRACCHIO A, BASSI C et al. Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma. J Exp Med 1993; 178: 151-161.
4. FREDSTROM S. Nitric oxide, oxidative stress, and dietary antioxidants. Nutrition 2002; 18: 537-539.
5. WINK DA, MITCHELL JB. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998; 25: 434-456.
6. LIRK P, HOFFMANN G, RIEDER J. Inducible nitric oxide synthase-time for reappraisal. Curr Drug Targets Inflamm Allergy 2002; 1: 89-108.
7. GOODE HF, WEBSTER NR, HOWDLE PD, WALKER BE. Nitric oxide production by human peripheral blood polymorphonuclear leucocytes. Clin Sci 1994; 86: 411-415.
8. BECK KF, EBERHARDT W, FRANK S, HUWILER A, MESSMER UK et al. Inducible NO synthase: role in cellular signaling. J Exp Biol 1999; 202: 645-653.
9. TAKEICHI O, SAITO I, OKAMOTO Y, TSURUMACHI T, SAITO T. Cytokine regulation on the synthesis of nitric oxide in vivo by chronically infected human polymorphonuclear leucocytes. Immunology 1998; 93: 275-280.
10. ROSBE KW, PRAZMA J, PETRUSZ P, MIMS W, BALL SS et al. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 1995; 113: 541-549.
11. JABLONSKA E, PUZEWSKA W, MARCINCZYK M, GRABOWSKA Z, JABLONSKI J. INOS expression and NO production by neutrophils in cancer patients. Arch Immunol Ther Exp 2005; 53: 175-179.
12. OLEE T, HASHIMOTO S, QUACH J, LOTZ M. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 1999; 162: 1096-1100.
13. YANAGITA M, SHIMABUKURO Y, NOZAKI T, YOSHIMURA N, WATANABE J et al. IL-15 up-regulates iNOS expression and NO production by gingival epithelial cells. Biochem Biophys Res Commun 2002; 297: 329-334.
14. DEPTALA A, NURZYNSKA D, DARZYNKIEWICZ Z, JEDRZEJCZAK WW. Rola bialek z rodziny Rel/NFκB/IκB w patogenezie nowotworów. Postepy Biologii Komórki 2002; 29: 48-56 (In Polish).
15. MCDONALD PP, RUSSO MP, FERRINI S, CASSATELLA MA. Interleukin-15 (IL-15) induces NF-κB activation and IL-8 production in human neutrophils. Blood 1998; 92: 4828-4835.
16. ZEMAN K. Methods of isolation of granulocytes. Immunol Pol 1990; 1: 157-170 (In Polish).
17. DEMBINSKA-KIEC A, BURCHERT M, HARTWICH J, GRYGLEWSKIR, PESKAR BA. A neutrophil-derived NO-synthase (NOS) inhibitor. Agents Actions Suppl 1995; 45: 163-168.
18. BAYLIS C, MITRUKA B, DENG A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278-281.
19. HORIUCHIN, AIBA S, OZAWAH, SUGAWARA S, RIKUSHI H et al. Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to beta-streptococcal superantigens. Br J Dermatol 1998; 138: 229-235.
20. VALLANCE P, LEONE A, CALVER A, COLLIER J, MONCADA S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20: S60-S62.
21. KOBASHI K, IWAGAKI H, YOSHINO T, MORIMOTO Y, KOHKA H et al. down-regulation of IL-18 receptor in cancer patients: its clinical significance. Anticancer Res 2001; 21: 3285-3293.
22. JABLONSKA E, PIOTROWSKI L, GRABOWSKA Z. Serum levels of IL-1β, IL-6, TNF-, sTNF-RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 1997; 3: 126-129.
23. BEEVI SS, RASHEED MH, GEETHA A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 2004; 34: 379-385.
24. GAVILANES J, MORO MA, LIZASOAIN I, LORENZO P, PEREZ A et al. Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck. Laryngoscope 1999; 109: 148-152.